Pharma Journalist -

Brooklyn ImmunoTherapeutics LLC announced it has acquired an exclusive license for mRNA gene editing and cell therapies technology of Factor Bioscience Limited and Novellus Therapeutics…
Read More...

Sirnaomics Biopharmaceuticals (Suzhou) Co. Ltd., a subsidiary of Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against…
Read More...

Catalent, the leading global provider of advanced delivery technologies, development, manufacturing, and clinical supply solutions for drugs, biologics, cell and gene therapies, and…
Read More...

Celltrion Group announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for the company’s…
Read More...

ADMA Biologics, Inc. an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that the U.S.…
Read More...

Implandata Ophthalmic Products, a digital health company with offices in Germany and San Diego, California has announced that its game-changing EYEMATE system for digitally enabled…
Read More...

SMi Group Reports: With less than two weeks to go until the conference, here are highlights of what will be covered at the 5th Annual HPAPi Virtual Conference, convening 10-11 May 2021.…
Read More...

ESSA Pharma Inc. clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced that the Company has entered into a clinical…
Read More...

Toxys and Unilever Safety and Environmental Assurance Centre (SEAC) have entered into an agreement to further validate and expand the ReproTracker assay. Testing for developmental…
Read More...

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced that their strategic collaboration has taken key steps…
Read More...